Advanced search
Publication Cover
Cancer Investigation Volume 21, 2003 - Issue 1
Submit an article Journal homepage
36
Views
16
CrossRef citations to date
0
Altmetric
Original

A Phase II Study of 13-cis Retinoic Acid Plus Interferon α-2a in Advanced Stage Penile Carcinoma: An Eastern Cooperative Oncology Group Study (E3893)

ORIGINAL ARTICLE

Roland T. Skeel M.D. Medical College of Ohio, Toledo, Ohio, USA
,
Jie Huang M.S. Dana-Farber Cancer Institute, Boston, Massachusetts, USA
,
Judith Manola M.S. Dana-Farber Cancer Institute, Boston, Massachusetts, USA
,
George Wilding M.D. University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, USA
,
Robert Dreicer M.D. Cleveland Clinic Foundation, Cleveland, Ohio, USA
,
Paul Walker M.D. Ball Memorial Hospital, Muncie, Indiana, USA
,
Franco Muggia M.D. New York University Medical Center, New York, New York, USA
,
E. David Crawford M.D. University of Colorado, Denver, Colorado, USA
,
Janice P. Dutcher M.D. Our Lady of Mercy Cancer Center, New York Medical College, Bronx, New York, USA
&
Patrick J. Loehrer M.D. Indiana University Medical Hospital, IndianapolisUSA
 show all
Pages 41-46 | Published online: 02 Nov 2003

REFERENCES

  • Herr H.H. Cancer of the urethra and penis. Cancer Principles and Practice, V.T., Jr. DeVita, S. Hellman, S.A. Rosenberg. Lippincott-Raven, Philadelphia 1997; 1386–1395
  • Maden C., Sherman K.J., Beckman A.M., Hislop T.G., Teh C.A., Ashley R.L., J.R. D. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J. Natl Cancer Inst. 1993; 85: 19–24
  • Malek R.S., Goellner J.R., Smith T.F., Espy M.J., Cupp M.R. Human papillomavirus infection and intraepithelial, in situ, and invasive carcinoma of penis [published erratum appears in urology 1994 Jan; 43(1): following table of contents]. Urology 1993; 42(2)159–170
  • Aboulafia D.M., Gibbons R. Penile cancer and human papilloma virus (hpv) in human immunodeficiency virus (hiv)-infected patient. Cancer Investig. 2001; 19(3)266–272
  • Sarin R., Norman A.R., Steel G.G., Horwich A. Treatment results and prognostic factors in 101 men treated for squamous cell carcinoma of the penis. Int. J. Radiat. Oncol. Biol. Phys. 1997; 38: 713–722
  • Lippman S.M., Parkinson D.R., Itri L.M., Weber R.S., Schantz S.P., Ota D.M., Schusterman M.A., Krakoff I.H., Gutterman J.U., Hong W.K. 13-Cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J. Natl Cancer Inst. 1992; 84: 235–241
  • Lippman S.M., Kavanagh J.J., Paredes-Espinoza M., Delgadillo-Madrueno F., Paredes-Casillas P., Hong W.K., Holdner E., Krakoff I.H. Highly active systemic therapy for squamous cell carcinoma of the cervix. J. Natl Cancer Inst. 1992; 84: 241–245
  • Lippman S.M., Kavanaugh J.J., Paredes-Espinoza M., Delgadillo-Madrueno F., Paredes-Casillas P., Hong W.K., Massimini G., Holdener E.E., Krakoff I.H. 13-Cis-retinoic acid plus interferon alpha-2a in locally advanced squamous cell carcinoma of the cervix. J. Natl Cancer Inst. 1993; 85: 499–500
  • Dmitrovsky E., Bosl G.J. Active cancer therapy combining 13-cis-retinoic acid with interferon alpha. (Editorial). J. Natl Cancer Inst. 1992; 84: 218–219
  • Smith M.A., Parkinson D.R., Cheson B.D., Friedman M.A. Retinoids in cancer therapy. J. Clin. Oncol. 1992; 10: 839–864
  • Hansen R.M., Borden E.C. Current status of interferons in the treatment of cancer. Oncology 1992; 57: 223–227
  • Frey J.R., R. P., Bollag W. Antiproliferative activity of retinoids, interferon-alpha, and their combination in five transformed cell lines. Cancer Lett. 1991; 57: 223–227
  • Shah K.V. Human papillomaviruses and anogenital cancers. N. Engl. J. Med. 1997; 337: 1386–1388
  • Kaplan E.L., Meier P. Nonparametric estimation of incomplete observations. J. Am. Stat. Assoc. 1958; 53: 457–481
  • Weiss G.R., Liu P.Y., Alberts D.S., Peng Y.M., Fisher E., Xu M.J., Scudder S.A., Baker L.H., Jr., Moore D.F., Lippman S.M. 13-Cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a southwest oncology group phase II randomized trial. Gynecol. Oncol. 1998; 71(3)386–390
  • Look K.Y., Blessing J.A., Nelson B.E., Johnson G.A., Fowler W.C., Reid G.C. A phase II trial of isotretinoin and alpha interferon in patients with recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study. Am. J. Clin. Oncol. 1998; 21(6)591–594
  • Park T.K., Lee J.P., Kim S.N., Choi S.M., Kudelka A.P., Kavanagh J.J. Interferon-alpha 2a, 13-cis-retinoic acid and radiotherapy for locally advanced carcinoma of the cervix: A pilot study. Eur. J. Gynaecol. Oncol. 1998; 19(1)35–38
  • Ahmed T., Sklaroff R., Yagoda A. Sequential trials of methotrexate, cisplatin and bleomycin for penile cancer. J. Urol. 1984; 132(3)465–468
  • Gagliano R.G., Blumenstein B.A., Crawford E.D., Stephens R.L., Coltman C.A., Costanzi J.J. Cis-diamminedichloroplatinum in the treatment of advanced epidermoid carcinoma of the penis: a Southwest Oncology Group Study. J. Urol. 1989; 141(1)66–67
  • Haas G.P., Blumenstein B.A., Gagliano R.G., Russell C.A., Rivkin S.E., Culkin D.J., Wolf M., Crawford E.D. Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a southwest oncology group study. J. Urol. 1999; 161(6)1823–1825
  • Hussein A.M., Benedetto P., Sridhar K.S. Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas. Cancer 1990; 65(3)433–438
  • Shammas F.V., Ous S., Fossa S.D. Cisplatin and 5-fluorouracil in advanced cancer of the penis. J. Urol. 1992; 147(3)630–632
  • Corral D.A., Sella A., Pettaway C.A., Amato R.J., Jones D.M., Ellerhorst J. Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin. J. Urol. 1998; 160(5)1770–1774

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.